http://umh1946.edu.umh.es/wp-content/uploads/sites/172/2015/04/Neurocircuitry-of-addiction1.pdf

Neurocircuitry of Addiction

Objective: A primary behavioral pathology in drug addiction is the overpowering motivational strength and decreased ability to control the desire to obtain drugs. In this review the authors explore how advances in neurobiology are approaching an understanding of the cellular and circuitry underpinnings of addiction, and they describe the novel pharmacotherapeutic targets emerging from this understanding. Method: Findings from neuroimaging of addicts are integrated with cellular studies in animal models of drug seeking.

/pdf/the-neural-basis-of-addiction-a-pathology-of-motivation-and-34ptcg5vfs.pdf

The Neural Basis of Addiction: A Pathology of Motivation and Choice

Addiction is associated with neuroplasticity in the corticostriatal brain circuitry that is important for guiding adaptive behaviour. The hierarchy of corticostriatal information processing that normally permits the prefrontal cortex to regulate reinforcement-seeking behaviours is impaired by chronic drug use. A failure of the prefrontal cortex to control drug-seeking behaviours can be linked to an enduring imbalance between synaptic and non-synaptic glutamate, termed glutamate homeostasis. The imbalance in glutamate homeostasis engenders changes in neuroplasticity that impair communication between the prefrontal cortex and the nucleus accumbens. Some of these pathological changes are amenable to new glutamate- and neuroplasticity-based pharmacotherapies for treating addiction.

The glutamate homeostasis hypothesis of addiction

Drug-Evoked Synaptic Plasticity in Addiction: From Molecular Changes to Circuit Remodeling

Mood disorders are common, chronic, recurrent mental illnesses that affect the lives of millions of individuals worldwide. To date, the monoaminergic systems (serotonergic, noradrenergic and dopaminergic) in the brain have received the greatest attention in neurobiological studies of mood disorders, and most therapeutics target these systems. However, there is growing evidence that the glutamatergic system is central to the neurobiology and treatment of these disorders. Here, we review data supporting the involvement of the glutamatergic system in mood-disorder pathophysiology as well as the efficacy of glutamatergic agents in mood disorders. We also discuss exciting new prospects for the development of improved therapeutics for these devastating disorders.

/pdf/targeting-the-glutamatergic-system-to-develop-novel-improved-43ircleu1u.pdf

Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders

Withdrawal from chronic cocaine reduces extracellular glutamate levels in the nucleus accumbens by decreasing cystine/glutamate exchange (xc-). Activating xc- with N-acetylcysteine restores extracellular glutamate and prevents cocaine-induced drug seeking. It was hypothesized that the activation of xc- prevents drug seeking by increasing glutamatergic tone on presynaptic group II metabotropic glutamate receptors (mGluR2/3) and thereby inhibiting excitatory transmission. In the first experiment, the capacity of glutamate derived from xc- to regulate excitatory transmission via mGluR2/3 was determined. Physiological levels of cystine (100-300 nm) were restored to acute tissue slices from the nucleus accumbens or prefrontal cortex. Cystine increased glutamate efflux and decreased miniature EPSC (mEPSC) and spontaneous EPSC (sEPSC) frequency as well as evoked EPSC amplitude. These effects of cystine were presynaptic, because there was no change in mEPSC or sEPSC amplitude, and an increase in the evoked EPSC paired-pulse facilitation ratio. The cystine-induced reduction in EPSCs was reversed by blocking either xc- or mGluR2/3. In the second experiment, blocking mGluR2/3 prevented the ability of N-acetylcystine to inhibit the reinstatement of drug seeking in rats trained to self-administer cocaine. These data demonstrate that nonsynaptic glutamate derived from xc- modulates synaptic glutamate release and thereby regulates cocaine-induced drug seeking.

https://www.jneurosci.org/content/jneuro/25/27/6389.full.pdf

Cystine/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking.

Cocaine addiction is characterized by an impaired ability to develop adaptive behaviors that can compete with cocaine seeking, implying a deficit in the ability to induce plasticity in cortico-accumbens circuitry crucial for regulating motivated behavior. We found that rats withdrawn from cocaine self-administration had a marked in vivo deficit in the ability to develop long-term potentiation (LTP) and long-term depression (LTD) in the nucleus accumbens core subregion after stimulation of the prefrontal cortex. N-acetylcysteine (NAC) treatment prevents relapse in animal models and craving in humans by activating cystine-glutamate exchange and thereby stimulating extrasynaptic metabotropic glutamate receptors (mGluR). NAC treatment of rats restored the ability to induce LTP and LTD by indirectly stimulating mGluR2/3 and mGluR5, respectively. Our findings show that cocaine self-administration induces metaplasticity that inhibits further induction of synaptic plasticity, and this impairment can be reversed by NAC, a drug that also prevents relapse.

/pdf/n-acetylcysteine-reverses-cocaine-induced-metaplasticity-1u4vah0wbt.pdf

N-Acetylcysteine reverses cocaine-induced metaplasticity

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− 6>3 + \" ! ! 5 * (, !\" / \" !$ = #! -. # $-\" $ ,*\" ! 29>> & 7) 3 * * # / ! ! * (\" + \" &-' * * #-\"$

Megan M. Moran

Papers

Cystine/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking.

N-Acetylcysteine reverses cocaine-induced metaplasticity

Cystine/glutamate antiporter regulation of vesicular glutamate release.